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Abstract
Background: Identification of minor cell populations, e.g. leukemic blasts within blood samples,
has become increasingly important in therapeutic disease monitoring. Modern flow cytometers
enable researchers to reliably measure six and more variables, describing cellular size, granularity
and expression of cell-surface and intracellular proteins, for thousands of cells per second.
Currently, analysis of cytometry readouts relies on visual inspection and manual gating of one- or
two-dimensional projections of the data. This procedure, however, is labor-intensive and misses
potential characteristic patterns in higher dimensions.
Results: Leukemic samples from patients with acute lymphoblastic leukemia at initial diagnosis and
during induction therapy have been investigated by 4-color flow cytometry. We have utilized
multivariate classification techniques, Support Vector Machines (SVM), to automate leukemic cell
detection in cytometry. Classifiers were built on conventionally diagnosed training data. We
assessed the detection accuracy on independent test data and analyzed marker expression of
incongruently classified cells. SVM classification can recover manually gated leukemic cells with
99.78% sensitivity and 98.87% specificity.
Conclusion: Multivariate classification techniques allow for automating cell population detection
in cytometry readouts for diagnostic purposes. They potentially reduce time, costs and
arbitrariness associated with these procedures. Due to their multivariate classification rules, they
also allow for the reliable detection of small cell populations.
Background
Flow cytometry has evolved to an indispensable tool in
biology and medicine, with a significant impact on hema-
tology. To date, diagnosis and classification of acute lym-
phocytic leukemia (ALL), depend on the flow-cytometric
description of the leukemic cell clone. Recently, flow
cytometry has also become an attractive approach for
evaluation of therapy response and especially detection of
minimal residual disease (MRD) [1]. Flow cytometry pro-
vides a quantitative cell description by a number of varia-
bles, including cell size, granularity and expression of cell-
surface and intracellular proteins. Due to the continuous
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development of flow cytometric techniques, their read-
outs have become increasingly complex and require ade-
quate analysis methods.
Current diagnostic evaluation of flow cytometry readouts
relies on simplistic two-dimensional analysis techniques.
The basis is a labor-intensive gating procedure. In a series
of two-dimensional dot plots, leukemic cells are manually
flagged by drawing polygons around regions, which are
known to contain mostly leukemic cells. A large number
of two-dimensional plots need to be inspected and several
regions need to be defined manually. Finally, candidates
for leukemic cells are those inside a Boolean combination
of drawn regions, called gate [2,3]. From the data analysis
perspective, gating lymphoblastic cells is a problem of
supervised statistical learning. One starts with a training
set of flow cytometry readouts, which are already gated by
an expert. The challenge is to derive a multivariate classi-
fication model from this data, which is able to produce
accurate gatings on different readouts that have not been
pre-gated by an expert. The objects of classification are sin-
gle cells that can either be leukemic or physiological lym-
phocytes. Typically, each cell is described by a 4–9
dimensional vector of flow cytometry measurements.
With only a small number of pre-gated readouts, one
already has several thousand training points. Problems
are posed by the non-linear shape of the regions contain-
ing leukemic lymphocytes and the patient-to-patient vari-
ability of these regions.
To our knowledge, replacing the manual gating process by
a computer-based automated multivariate analysis has
not been described previously. Some cytometer software
suites contain tools for automated walk-away  analyses
once the gates have been defined. These tools, however,
are also restricted to two-dimensional decision rules. In
addition, some methods to make use of cytometry read-
outs in a multivariate setting have been proposed. Here,
we briefly review three of these methods and explain the
differences to our concept.
Valet et al. [4] introduced a classification method for
blood samples in flow cytometry, called algorithmic data
sieving. For each class of samples, a discretized representa-
tive is derived from training data. New samples are then
classified according to their similarity to these representa-
tives. De Zen et al. [5] investigated the feasibility to clas-
sify acute-leukemia subtypes on flow-cytometry readouts.
First, they determined the leukemic cells by a conven-
tional, manual gating procedure and discarded all other
cells from the data. For each sample, they summarized the
measurements over all leukemic cells for each variable
and used these summary values for classifying samples
with linear discriminant analysis [6]. Roederer and Hardy
[7] proposed an algorithm for sample comparison based
on cytometry readouts. Their algorithm identifies multi-
dimensional hyper-rectangular bins that significantly dif-
fer in the proportion of cells contained between a test
sample and a control sample. The union of all these
regions comprises a frequency difference gate. This gate may
be used to assign new samples to test or control group, as
well as to find differences between similar types of cells
under different conditions. While their approach could be
modified to search for regions in multivariate space,
which differ between leukemic and non-leukemic sam-
ples, they restrict these regions to be rectangles, which is
not the case in conventional gating [3]. Moreover, in this
case regions are not required to contain the same propor-
tion of cells but rather to contain mostly cells of the same
class. In contrast to these approaches, we are not inter-
ested in classifying blood samples based on their cytome-
try readouts, but rather in automated identification of cell
populations within the samples. We report on the appli-
cability of statistical learning methodology, for achieving
automated, reliable in-silico gatings on flow cytometry
readouts. To this aim, we employ supervised classification
with Support Vector Machines [8].
Results
Algorithm
For supervised classification of the leukemic status of
cells, we employ a Support Vector Machine based algo-
rithm that allows for non-linear decision boundaries in
the input space spanned by the cells' measured character-
istics and protein expression levels. Our algorithm takes
into account outstanding properties of flow-cytometry
readout data, namely
• samples consisting of tens of thousands of individual
observations
• large inter-sample variation due to non-standardized
methods of obtaining measurements.
Support Vector Machines
Support Vector Machines (SVM) [9,10] are a class of regular-
ized multivariate classification models that are widely
used for predictive modelling of multidimensional data.
We provide a quick review of SVM here. Let X be the data
matrix holding n observations xi, with i ∈ 1,..., n, in col-
umns and p variables in rows. The observations xi are said
to reside in a p-dimensional input space. For each obser-
vation xi its class (clinical phenotype) yi ∈ {± 1} is known
beforehand in case of the training set or to be predicted in
case of the test set. SVM fit a maximal (soft) margin hyper-
plane between the two classes. With high-dimensional
problems, there may be several perfectly separating hyper-
planes (the maximum likelihood approach leads to an ill-
posed problem). There is, however, only one separatingBMC Bioinformatics 2006, 7:282 http://www.biomedcentral.com/1471-2105/7/282
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hyperplane with maximal distance to the nearest training
points of either class.
More formally, among all hyperplanes of the form
w·x + b = 0 | w ∈ N, b ∈ 
corresponding to linear decision functions
c(xj) = sgn(w·xj + b)
there exists one that maximizes the distance of each input
vector to the hyperplane. It can be shown, that this optimal
hyperplane can be empirically obtained from data X by
solving
where
In practice, αi will often be zero for many i and different
from zero for only a limited number of m observations
with m ≤ n. These m observations solely define the sepa-
rating hyperplane and are called support vectors. The maxi-
mal-margin concept is typically combined with the kernel
trick to allow for flexible non-linear classification bound-
aries. The kernel trick is applicable to classification algo-
rithms that can be expressed in terms of inner products of
the inputs, as it is the case for the maximum-margin
hyperplane. The inner products are substituted by a kernel
function k(xi, xj), which corresponds to a feature map Φ that
maps the profiles from the input space into a feature space
:
Φ: p → 
x  Φ(x).
This results in the original algorithm being carried out in
 now and leads to non-linear decision boundaries in
the input space. After application of the kernel trick, the
decision functions are of the more general form
Soft margin classification
Noise may cause large overlap of the classes even in the
feature space, such that a perfectly separating hyperplane
may not exist. In this case, one can allow for misclassifica-
tions (margin violations) by relaxing the optimization
constraints to
yi·(w·xi + b) ≥ 1 - ξi, i = 1,..., n.
ξi ≥ 0 are commonly called slack variables. The optimal soft
margin classifier is then found by minimizing the regular-
ized risk function
In this formulation, perfect separability of the two classes
is not required and margin violations are allowed. The
trade off between margin violations and margin size is
reflected by the regularization (cost) parameter C.
Regularization is essential to counter the additional flexi-
bility acquired by use of the kernel trick.
In recent years, SVM have proven to be a powerful and
robust classification method that can handle various
kinds of input data [11]. For a more extensive introduc-
tion to SVM see, e.g, [8].
We chose a radial-basis kernel function, which can be
defined as:
kγ(xi, xj) = exp(-γ·||xi - xj||2)
where xi and xj are two input data points and γ  is the
inverse band width of the smoothing kernel.
Building the classifier
With our data, we applied the SVM to separate leukemic
from non-leukemic cells. The optimal settings for the SVM
parameters C and γ were determined on set-aside calibra-
tion data, while the actual performance of the SVM classi-
fier was analyzed on another set-aside test data set. Since
our samples each contained up to 300,000 cells, requiring
highly demanding computations, we had to think about
methods of data reduction. Since with SVM classification,
the decision boundary is only determined by the support
vectors [[8], chap. 1], we can discard all observations that
are not support vectors from the training data. We split the
data into subsets, keeping only the support vectors from
each subset and build the final SVM classifier on the sets
of support vectors, similar to Boser et al. [12]. In detail, we
used the following procedure to estimate the test error of
the learned classifier:
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1. Split data into 50% training set, 25% calibration set,
and 25% test set.
2. For a reasonable number of possible parameter settings
Θk = (γk, Ck):
(a) initialize an empty set of training vectors  k = { }
(b) split training set into computationally feasible subsets
(c) for each of these subsets
• learn SVM-classifier for leukemic versus non-leukemic
cells
• identify support vectors S on this subset
• include these support vectors into the set of training vec-
tors  k =  k ∪ S
(d) learn SVM-classifier on  k
(e) use learned classifier on calibration set to compute the
calibration error ϕk
3. Keep learned classifier with lowest calibration error.
4. Use this classifier to predict test data.
5. Return prediction error on test set as test error.
Keeping only the support vectors from each data subset
reduces the amounts of involved data and renders the
computations feasible on common present-day comput-
ers.
The final test error provides an unbiased estimate of the
classifier's prediction error (generalization error) on new
data [13, chap. 7].
Artificial noise
We are interested in building classifiers that are insensitive
to minor noise induced into experimental measurements
by the experimental setup or measuring device. By gener-
ating artificial noise and applying it to training data, one
tests the ability to learn a "correct" concept in the presence
of noise [14]. Here, we add artificial noise to our training
data to simulate such minor experimental variations. As
noise, we take random normally distributed numbers.
Classification rules that are built on noisy versions of the
training data and apply to artificial-noise-free test data as
well, have the potential to generalize better to new test
samples [15].
Application on patient data
In each of 37 patient samples (Table 1), the leukemic cells
were identified by manual gating beforehand. We then
randomly assigned 19 patient samples to a training set,
while the remaining 18 patient samples made up the test
set. We also included two other samples, for which the
proportion of leukemic cells was predefined, into the
training set. One of these samples originated from a non-
leukemic blood sample (sample 38 in Table 1) while the
other one was enriched with leukemic cells by Ficoll gra-
dient-density centrifugation and subsequent manual fil-
tering of the flow cytometry data upon visual inspection
(sample 39 in Table 1).
From each sample of the training set, we randomly drew
10,000 cells and discarded all other cells. Thus, our train-
ing data consisted of 210,000 cells and the associated
labels, either "leukemic" or "non-leukemic".
To simulate minor experiment-induced variations, we
added random noise to the data. For each variable, we
determined its standard deviation across all cells of the
training data. We then drew random numbers from a nor-
mal distribution with mean 0 and standard deviation
equal to 10% of the variable's observed standard devia-
tion. These random numbers were added to the values of
the training data.
On the noisy training data, we learned the optimal SVM
classifier and evaluated its classification performance on
the test set as well as on the two samples with predefined
leukemic proportion.
For building the SVM classifier, we again split the training
data into an actual training set, a calibration set and a test
set to select the optimal parameter settings and to avoid
overfitting.
The SVM defines a region in six-dimensional space con-
taining the leukemic cells. Due to the kernel trick, the clas-
sification boundary between points in the six-
dimensional space, at which cells would be classified as
being leukemic, and the other points, at which cells would
be classified as physiological blood cells, is a non-linear
structure. To illustrate this, we presenl a projection of this
region on the three-dimensional subspace spanned by the
variables SSC, CD34 and CD10 (Figure 1).
The SVM classifier employs a radial-basis kernel function
with parameters σ = 0.5 and C = 4. However, changing
each parameter selling by up to 25% had no effect on the
classification performance, underlining the robustness of
the method. The SVM classifier is based 958 support vec-
tors, of which 478 are leukemic cells. On the training data,

 
BMC Bioinformatics 2006, 7:282 http://www.biomedcentral.com/1471-2105/7/282
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the learned radial-basis SVM classifier achieves a classifi-
cation accuracy of 99.6%.
For comparison, we also evaluated the classification per-
formance of an SVM classifier utilizing a linear kernel
function instead of a radial basis one. We observed a
slightly worse performance of this classifier on the train-
ing data, namely an error of 0.7%.
We used the SVM classifier to predict leukemic cells in the
two samples, either without or enriched with leukemic
cells, respectively. Cells from both samples had been used
for learning the SVM as well, but we made sure that the
same cells would not be used for testing the SVM perform-
ance. From the non-leukemic sample, we drew a subsam-
ple of 20,000 cells at random to avoid exceeding available
RAM during computations for the SVM prediction. Of
these 20,000 cells, only 2 (0.01%) were misclassified as
being leukemic (sample 38, Table 1). From the enriched
Table 1: Sample characteristics. Sample No.: Sample Number, Patient No.: Patient Number (S: custom-built mix samples), Day: Day 
of treatment (d0: before initial treatment, d8: after first week of treatment, d15: after second week of treatment), Source: Source of 
sample (BM: bone marrow, PB: peripheral blood, Co: control), Man.% Leukemic: Percentage of events deemed leukemic by manual 
gating. SVM % Leukemic: Percentage of events deemed leukemic by SVM prediction.
Sample No. Patient No. Day Source Man. % Leukemic SVM % Leukemic
1 I d8 PB 5.88 5.88
2 II d8 PB 0.04 0.03
3 III d0 BM 66.33 64.28
4 III d0 PB 68.09 67.92
5 III d8 PB 0.26 0.32
6 IV d0 BM 82.28 82.05
7 IV d0 PB 6.23 6.12
8 V d0 BM 31.83 30.82
9 V d0 PB 13.76 13.17
10 III d15 BM 0.00 0.03
11 IV d8 PB 0.68 0.66
12 V d8 PB 0.08 0.08
13 VI d0 BM 86.32 88.13
14 VI d0 PB 56.59 56.97
15 VII d0 BM 82.41 82.63
16 VII d0 PB 44.67 44.64
17 VIII d0 BM 82.87 91.31
18 VIII d0 PB 59.34 62.34
19 IX d0 BM 78.59 78.44
20 IX d0 PB 41.81 41.76
21 X d0 BM 38.18 37.63
22 X d0 PB 8.93 9.15
23 IV d15 BM 0.22 0.50
24 V d15 BM 0.22 0.27
25 VIII d8 PB 0.33 0.47
26 VII d8 PB 0.96 0.97
27 VI d8 PB 0.46 0.53
28 IX d8 PB 0.93 1.02
29 XI d0 BM 29.35 30.05
30 XI d0 PB 11.24 11.13
31 X d8 PB 0.81 0.82
32 VIII d15 BM 0.48 0.40
33 VII d15 BM 0.55 0.52
34 VI d15 BM 0.19 0.21
35 IX d15 BM 1.01 1.02
36 X d15 BM 0.41 0.49
37 XI d15 BM 0.02 0.02
38 s Co 0.00 0.01
39 s Co 100.00 97.12
40 s 0.01 0.01 0.01
41 s 0.1 0.10 0.08
42 s 1.0 1.00 0.82
43 s 10 10.00 9.41BMC Bioinformatics 2006, 7:282 http://www.biomedcentral.com/1471-2105/7/282
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leukemic sample (containing approx. 94% leukemic
blasts), we also drew a random subsample of 20,000 cells.
Of these, the SVM classified 576 (2.88%) as being non-
leukemic (sample 39, Table 1).
We utilized the learned SVM to predict the leukemic status
of the cells in the test set, which consisted of 18 patient
samples that had not been involved in training the classi-
fier. We compared the predicted leukemia status with the
one determined by gating beforehand. On this independ-
ent test set, the SVM achieved a sensitivity of 99.78% and a
specificity of 98.87% for predicting the leukemic status of
cells. In summary, for 0.94% of the cells of the test data,
the leukemia status differed between SVM prediction and
gating assignment. The total number of true and wrong
predictions can be seen in Table 2.
To evaluate the robustness of the observed classification
performance, we repeated the random splitting of patient
samples into training and test set 500 times, and reran the
full analysis for each split. The mean sensitivity was
98.06% (95% confidence interval [CI] 88.7% to 99.8%)
and the mean specificity was 99.27% (95% CI 98.6% to
99.9%), which confirms the stability of our results. Across
the 500 random splittings on average, we observed 2006
support vectors (sd: 496), which is more than for the orig-
inal splitting.
To further assess the built classifier's precision, we took
another independent peripheral blood sample, which was
taken on the initial day of treatment, and separately meas-
ured aliquots from this sample with intervals of several
minutes in between. Cytometer settings were not changed
in between measurements. On each of the six readouts, we
applied the classifier to predict the percentage of leukemic
cells included. The predicted values ranged from 21.19%
to 21.99% percent, similar to the manual-gating assigned
percentage range that extented from 20.55% to 21.94%.
We compared the spatial distribution of cells being classi-
fied as leukemic by the SVM to that of cells deemed leuke-
mic due to manual gating and to the spatial distribution
of all cells in the test data (see Figure 2). The distributions
of cells deemed leukemic by manual gating and by SVM
classification are nearly identical. However, the area in
multivariate space, in which the SVM would assign cells to
the leukemic class, is slightly larger than that defined by
manual gating.
The large majority (96.8%) of the incongruently classified
cells are deemed to be physiological blood cells by man-
ual gating but predicted as being leukemic by the SVM.
Most of these stem from samples taken before initial treat-
ment (see Table 2). Their scatter and fluorescence meas-
urements, compared to those cells deemed leukemic by
both methods, can be seen in Figure 3.
Discussion
Modern flow cytometers enable researchers to reliably
measure six and more variables, such as size, shape and
expression of cell-surface and intracellular proteins, for
thousands of cells per second. In leukemia research, one
is interested in the identification of leukemic cells, which
are characterized by abnormal patterns of surface marker
Table 2: SVM prediction on test data. This table displays the numbers of true and wrong predictions by the SVM classifier on test data, 
taken from 18 patient samples not involved in training the classifier. Rows hold the category the cells have been assigned to by manual 
gating, columns hold the SVM predicted category. In brackets: Percentage of cells in that gating-assigned category.
SVM Leukemic SVM Physiological Total
Leukemic by gating 37,536 (99.78%) 83 (0.22%) 37,619
Physiological by gating 1,602 (1.13%) 140,779 (98.87%) 142,381
Total 39,138 (27.7%) 140,862 (78.3%) 180,000
SVM classification on a three-dimensional subspace Figure 1
SVM classification on a three-dimensional subspace. 
Shown are points, at which cells would be classified as being 
leukemic by the learned SVM, in a three-dimensional sub-
space of the six-dimensional space spanned by all variables. 
The three variables not shown are fixed at their median 
value. The color of the points is meant to emphasize the 
three-dimensionality of the plot, with brighter points being 
closer to a hypothetical observer in front of the plot.BMC Bioinformatics 2006, 7:282 http://www.biomedcentral.com/1471-2105/7/282
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Comparison of detected leukemic cells Figure 2
Comparison of detected leukemic cells. This figure displays the distribution of cells drawn at random from the test data 
that consists of 18 combined patient samples The plots in each row show the density distribution of the same cells with 
respect to their expression of the variables denoted on the axes. The darker an area in each plot, the more cells lie within that 
area. Upper row: All measured cells are shown. Middle row: Only cells deemed leukemic by manual gating are shown. 
Lower row: Only cells deemed leukemic by the built SVM classifier are shown.
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expression. The physiological co-expression patterns of
these proteins during blood-cell development hints to a
tight regulation of the expression of these markers. Search-
ing for abnormal expression patterns with analysis tech-
niques employing at most two markers at the same time
has been successfully established in clinical leukemia
research [3]. However, these techniques, such as gating,
are labor-intensive, subjective and not able to capture
higher-order dependencies between measured variables.
Some existing methods make use of the multivariate set-
ting of cytometry readouts [4,5,7], but these methods aim
at sample classification based on the readouts rather than
on cell population detection within samples.
Here, we have shown the potential of well-established
multivariate-analysis techniques, such as classification via
SVM, to automate detection of leukemic cells in flow
cytometry readouts from patients' bone marrow and
peripheral blood samples. The SVM operates in the space
spanned by all variables and even augments it by the use
of the kernel trick [8]. Classification in this complex space
takes into account higher-order dependencies between
the variables, which are disregarded when restricting one-
self to one- or two-dimensional decision rules. With flow
cytometry, there is no denying that dependencies between
the measured variables do exist, due to properties of uti-
lized materials and biological, superordinate regulatory
mechanisms. Developing blood cells are characterized by
combinations of interacting surface markers [16]. Also,
measured fluorescence intensities cannot be considered
independent from each other because of overlaps between
the fluorochromes' emission spectra [17]. Most cytome-
ters can be set to compensate for these overlaps. While this
compensation removes part of the influence of each meas-
ured variable on the others, one cannot expect it to
remove every dependence between them.
We built a SVM classifier on the training data, containing
approx. 50% of the available data. We, again, split the
training data into separate sets for building the classifier,
selecting the optimal parameter settings, and assessing the
training error. This procedure and the artificial noise
added to the training data prevent overfitting of the
learned SVM classifier. The learned SVM had a very low
training error of 0.4%. Remarkably, this error did not
increase, when modifying the SVM's parameter sellings by
up to 25%, indicating a very clear separation of leukemic
and non-leukemic cells in the enhanced feature space.
We tested the learned radial-basis SVM classifier on inde-
pendent test data, generated from a non-leukemic blood
sample, an enriched leukemic sample and 18 patient sam-
ples not used for training the classifier. On the non-leuke-
mic sample, only 0.01% of the physiological blood cells
were misclassified as being leukemic. These few misclassi-
fied cells display physical properties and surface marker
expression similar to physiological B-lymphocyte precur-
sors (data not shown). While such immature cells are usu-
ally restricted to the bone marrow, they have been
described to appear in peripheral blood in small quanti-
ties [18]. On the enriched leukemic sample, only 2.88%
of the cells were predicted to be non-leukemic cells, a per-
centage of remaining physiological cells to be expected
Leukemic cells detected solely by the SVM Figure 3
Leukemic cells detected solely by the SVM. In this figure, the distribution of those cells, which were deemed to be phys-
iological blood cells by conventional gating, but classified as leukemic by the SVM (red dots) is displayed. For comparison, to the 
density distribution of those cells deemed leukemic by both methods is also shown (blue background densities). The darker a 
blue area is, the more confirmed leukemic cells lie within that area.
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with the density-gradient centrifugation method for
leukemic cell enrichment.
We applied the classifier on separately measured aliquots
of one single sample to evaluate the classifier's precision.
We observed a maximal difference of 0.8% between the
predicted leukemic-cell proportion in any two of these
aliquots, underlining the precision of SVM classification
on cytometry readouts.
The built SVM classifier was applied to identify leukemic
cells in independent patient test samples. In these sam-
ples, leukemic cells had been pinpointed beforehand by
conventional gating [3]. By SVM-classification, we could
recover these leukemic cells with a sensitivity of 99.78%
and a specificity of 98.87% (see Table 2). A comparison of
the spatial distribution of cells deemed leukemic by man-
ual gating with that of cells classified as leukemic by the
SVM shows that both distributions are highly similar, but
SVM-predicted leukemic cells encompass a slightly larger
area than gated ones (Figure 2).
Nearly all (99.06%) cells were classified congruently by
both methods. Importantly, in the day-8 and day-15 sam-
ples, taken after the first and second treatment phase, only
a small number of incongruently classified cells were
observed. The SVM approach successfully recovered the
small leukemic cell populations remaining at this stage,
thus demonstrating its promising potential in the identi-
fication and monitoring of small leukemic subpopula-
tions during leukemia therapy.
Most of the cells that were incongruently classified by
manual gating and SVM prediction are deemed non-
leukemic by gating but leukemic by the SVM (see Table 2).
These cells generally display a light scattering typical of
leukemic lymphocytes, and the majority of them show a
CD19 and CD34 expression similar to that of leukemic
cells detected by manual gating (Figure 3). Their main
population is also characterized by a low CD20- and inter-
mediate CD10 expression compatible with a leukemic
immunophenotype. However, since their CD10 expres-
sion tends to be lower than that of the gating-identified
leukemic cells, these cells were not included in the leuke-
mic population by conventional gating.
As such staining variations can arise, e.g., from incomplete
staining of cells in the experiment, they decrease the sen-
sitivity of leukemic cell detection by low-dimensional gat-
ing. In contrast, the SVM classification is based on all
variables at once, and slight variations in only one varia-
ble do not hinder the detection of cell populations as long
as the remaining variables are characteristic for the
sought-after populations. This highlights the strength of
the multivariate approach described here.
Also in Figure 3, it can be seen that a small cell subpopu-
lation with low to intermediate CD19 expression was clas-
sified as being leukemic by the SVM. Although the CD19
expression of these cells may have been considered below
borderline in conventional gating for leukemic B-cells, the
artificial noise added to the training data shifted the SVM's
decision boundary to include these cells.
The artificial noise seems to be advantageous for learning
classification rules in the flow cytometry setting. Various
sources of variability arising in the experimental proce-
dure, such as sample contamination, incomplete staining,
and instrument instability, can induce shifts in fluores-
cence and scattering measurements [3]. Classification
rules that apply to noisy and noise-free cytometry read-
outs may be insensitive to such shifts.
Compared to related approaches [4,7], the SVM approach
has the advantage that it does not require any control
sample group. Thus, it obviates the need to take blood
samples from healthy persons. Instead, it is based on a
given cell classification, gained from established diagnos-
tic procedures. The SVM approach also does not require a
discretization of the numerical data, which would reduce
the data's information content, but allows for stable event
classification in the high-dimensional space spanned by
all measured variables. It does not aim at assigning sam-
ples to classes, but rather at assigning single cells to prede-
fined groups. Therefore, no summarization of a variable's
distribution over all cells is required.
Conclusion
The SVM's high classification accuracy is promising, given
the fact that the classifier has been build and tested on
independent data sets and the training data had been arti-
ficially contaminated. Automating the gating for leukemic
cells in flow cytometry readouts from blood and bone
marrow samples seems highly feasible, even with moder-
ate variations in the experimental procedure.
Furthermore, the SVM automation is applicable to any
gating-like procedure for identifying, even small, sub-
groups of cells in flow cytometry readouts. One of these
applications could be the identification of MRD blast cells
and monitoring of response to therapy in ALL.
Multivariate classification allows for reliable automation
of current diagnostic procedures, taking into account bio-
logical dependencies that provide obstacles to simplistic
methods. It has the potential to greatly reduce the time,
costs and arbitrariness associated with these procedures
and allows for shifting efforts to potential research exten-
sions.BMC Bioinformatics 2006, 7:282 http://www.biomedcentral.com/1471-2105/7/282
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In addition, our results show that classification tech-
niques, whose use is already well established on common
biological data types, such as gene expression data, can
give rise to new algorithms for the analysis of various
other existing and upcoming kinds of biological high-
throughput data.
Methods
Cells and cell staining
Leukemic samples (n = 37) from a series of patients with
childhood precursor B-cell ALL (PBC-ALL) collected at
initial diagnosis (d0-samples from bone marrow, BM, or
peripheral blood, PB), after seven days of initial therapy
(d8-samples from PB) and after two weeks of initial ther-
apy (d15 samples from BM) were investigated. In addition
to the leukemic samples, an artificial dilution series (n = 6
custom-built mix samples) was generated by mixing
blood cells, which had been enriched in leukemic cells by
Ficoll density gradient centrifugation, with whole periph-
eral blood cells from a healthy donor. The sample data on
all 43 samples investigated, including estimated percent-
age of leukemic cells, are shown in Table 1. The cell sam-
ples were processed using a BD FACS Lysing Solution
(Becton Dickinson, San Jose, CA), according to the manu-
facturer's instructions, and subsequently stained with a 4-
color combination of fluorochrome-conjugated mono-
clonal antibodies: anti-CD10 phycoerythrin (Dako, Glos-
trup, Denmark), anti-CD20 fluorescein (Becton
Dickinson), anti-CD34 phycoerythrin-cyanin 5.1, and
anti-CD19 phycoerythrin-cyanin 7 (Coulter-Immu-
notech, Hialeah, FL). Measurements of antigen expression
were performed by multi-parameter flow cytometry using
a FC500 flow cytometer equipped with the Cytomics RXP
Analysis Version 1.0 software (Beckman Coulter, Miami,
FL). Instrument setup as well as calibration and compen-
sation procedures have been performed according to the
recommendations given in [19] and as described in [1].
Analog signals were digitized at 1024-channel resolution.
For each sample, the two light-scattering variables FSC
and SSC plus four surface markers, CD20, CD10, CD34,
and CD 19, were quantified for (50 – 300) 103 cells. Rea-
douts from the flow cytometry experiments were provided
in a standardized file format, called Flow Cytometry
Standard (FCS), version 3.0 [20]. The readouts were com-
pensated to reduce effects stemming from overlapping
emission spectra of utilized fluorochromes.
Manual gating
Upon inspection of cells in a two-dimensional dot-plot,
cells within a region of interest can be marked, by manu-
ally drawing a polygon around them. Many algorithms
exist to determine which cells are within the drawn poly-
gon. Once determined, these cells can be highlighted in
color, and/or separated from the other cells for further vis-
ualization or computations. Currently in leukemia
research, cells, which are possibly leukemic, are pin-
pointed by researchers manually drawing polygons
around cells in a number of two-variable dot plots. Shape
and position of such defined regions depend on the sub-
jective expertise of the researcher and are not restricted to
rectangles at fixed positions. Finally, candidates for leuke-
mic cells are those inside a Boolean combination of
drawn regions, called gate [2,3].
Implementation
All computational methods were implemented in the sta-
tistical programming language R [21]. Analyses were con-
ducted using custom functions, which depend on released
R packages. We used the SVM implementation of the
package  e1071  [22]. Our custom functions have been
assembled into a new R-package, called cytomics, which is
available from the authors upon request.
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